4 ms·
That's what it sounds like. Possibly safer and simpler than viral immunoconological vectors. I guess the issue is identifying the very specific histological ano
by doggodaddo78 6y ago
That's what it sounds like. Possibly safer and simpler than viral immunoconological vectors. I guess the issue is identifying the very specific histological anomalies in cancer cells to target SARS-CoV-2-spikes style. Perhaps this can be done by flow cytometry and sequencing of healthy cells vs. cancer cells. The big challenge is making certain no other cells share the targeted structures.